Zip-Codes: Cell Specific Therapeutic Platform

Non-Viral, Precise and Specific

Read About Our Team

Therapeutic Targeting Platform

Targeted, Flexible, Efficient

Our Zip-Code™ Technology platform is a first in class, cell-specific delivery system that can be used for a broad range of gene therapy applications. Because the Zip-Codes ™ are derived from an endogenous human mechanism it avoids all of the challenges of viral delivery approaches. The Zip-Codes ™ are universally applicable and specific for each cell type.

Our Science

Groundbreaking, Pioneering, Ushering in a New Era of Gene Therapies

Our science is redefining the boundaries of medicine, fueling new therapeutic approaches and providing a diversity of tools to oncologists and hope to families and patients with cancer.

About Us: Team and Advisors

Management Team

Anthony Johnson

Co-Founder & CEO

Anthony Johnson is an experienced executive with a strong track record of leadership across the healthcare sector. His experience has covered a multitude of areasMore details

Dr. Leon Bernal-Mizrachi

Co-Founder, CSO

Leon Bernal-Mizrachi, MD, is Associate Professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine. Dr. Bernal serves as theMore details

Dr. Stephen Chang Ph.D.

Senior Vice-President Research

Dr. Stephen Chang serves on the Scientific Advisory Board or Board of Directors for GT Biopharma, Orphesus Therapeutics, Cloak Therapeutics, Aegis Therapeutics and Legacy Therapeutics.More details

News & Updates

Contact Us

180 Varick Street, 6th Floor
New York, NY 10014
Emory University
1365 Clifton Road, Atlanta, GA 30322